查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1887692

全球聚合酵素鏈鎖反應市場

Polymerase Chain Reaction
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球聚合酵素鏈鎖反應（PCR）市場預計到2030年將達到131億美元

全球聚合酵素鏈鎖反應(PCR) 市場規模在 2024 年估計為 98 億美元，預計到 2030 年將達到 131 億美元，在分析期（2024-2030 年）內複合年成長率 (CAGR) 為 5.0%。本報告分析的儀器細分市場預計將以 4.9% 的複合年成長率成長，並在分析期結束時達到 34 億美元。試劑和耗材細分市場預計在分析期內將以 5.0% 的複合年成長率成長。

美國市場規模估計為26億美元，而中國市場預計將以7.6%的複合年成長率成長。

據估計，2024年美國聚合酵素鏈鎖反應（PCR）市場規模將達26億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到29億美元，2024年至2030年的複合年成長率（CAGR）為7.6%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率分別為2.7%和4.4%。在歐洲，德國的複合年成長率預計約為2.9%。

全球聚合酵素鏈鎖反應（PCR）市場－主要趨勢與促進因素概述

聚合酵素鏈鎖反應：現代分子生物學的基石

聚合酵素鏈鎖反應(PCR) 是分子生物學領域的突破性技術，能夠擴增特定的 DNA 序列。 PCR 由 Kary Mullis 於 1983 年開發，使研究人員能夠在相對較短的時間內將特定的 DNA 片段擴增至數百萬拷貝。這個過程涉及反覆的加熱和冷卻循環，從而促進 DNA 雙螺旋的變性、引子與目標序列的退火以及 DNA聚合酵素對這些引子的延伸。反應混合物通常包含 DNA 模板、兩個引子、遊離核苷酸、緩衝液和耐熱 DNA聚合酵素（例如 Taq聚合酵素） ，後者能夠承受變性所需的高溫。這個循環過程能夠指數級擴增目標 DNA 區域，使 PCR 成為遺傳研究、診斷和法醫學中不可或缺的工具。

PCR技術在各領域有哪些應用？

聚合酶鍊式反應（PCR）具有快速、精確擴增DNA的能力，因此廣泛應用於各個科學和醫學領域。在醫學診斷中，它用於檢測和定量細菌、病毒等病原體，從而能夠識別愛滋病、肝炎和新冠肺炎等感染疾病。基因檢測還能辨識與遺傳疾病相關的突變，有助於早期診斷和製定個人化治療方案。在法醫學中，PCR對於分析從犯罪現場採集的微量DNA樣本至關重要，能夠提供將嫌疑人與犯罪活動聯繫起來的證據。此外，PCR在生物技術和製藥行業的研發中也發揮著重要作用，用於克隆、基因表現分析以及基因改造生物的建構。 PCR的多功能性和精確性使其成為增進我們對遺傳學理解、改善公共衛生和安全的關鍵技術。

PCR技術及其應用目前的發展趨勢為何？

在分子生物學進步和對快速、精準基因分析日益成長的需求推動下，PCR技術及其應用不斷發展。其中一個關鍵趨勢是定量PCR（qPCR）或即時PCR的發展，它能夠即時定量DNA和RNA，從而為基因表現和病毒量提供寶貴的資訊。數位PCR（dPCR）是一種新興技術，它將樣本分成數千個獨立的反應，從而實現核酸的絕對定量，並具有高精度和高靈敏度。微流體技術的進步促成了攜帶式PCR設備的開發，使得在資源匱乏地區和現場進行基因檢測成為可能。此外，多重PCR能夠在單次反應中擴增多個靶標，透過減少時間和試劑消費量，提高了基因檢測的效率。這些趨勢反映了人們為提高PCR的準確性、效率和可近性，並拓展其在各個領域的潛在應用所做的持續努力。

哪些因素正在推動PCR市場的成長？

PCR市場成長受多種因素驅動，反映出對先進基因分析和診斷工具日益成長的需求。醫療領域的不斷拓展，尤其是感染疾病的日益普及和對早期診斷的需求，是推動PCR技術發展的關鍵因素。 qPCR和dPCR等技術的進步提高了PCR的效力和準確性，促進了其在各個應用領域的普及。對個人化醫療的日益重視以及對精準基因檢測以指導治療決策的需求，也是推動市場成長的因素。此外，生物技術和製藥產業研發投入的增加，也推動了藥物發現和基因工程領域對PCR的需求。 PCR在法醫學和環境監測領域的日益廣泛應用，也進一步促進了市場擴張。持續不斷的研發投入，旨在創新和改進PCR技術，確保了PCR市場的穩健成長，凸顯了其在推動分子生物學發展和改善公共衛生方面的重要作用。

部分：

按最終用戶（學術和研究機構、臨床診斷檢查室和醫院、製藥和生物技術產業、其他最終用戶）；按細分市場（設備、試劑和耗材）分類

受訪公司範例

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • QIAGEN NV
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，革新市場和競爭情報分析。

Market Glass, Inc. 並沒有採用典型的 LLM 或產業專用的SLM 方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在地、製造地以及進出口（成品和OEM產品）情況，預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手，包括增加銷貨成本、降低盈利和重組供應鏈，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP14084

Global Polymerase Chain Reaction Market to Reach US$13.1 Billion by 2030

The global market for Polymerase Chain Reaction estimated at US$9.8 Billion in the year 2024, is expected to reach US$13.1 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the Reagents & Consumables segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 7.6% CAGR

The Polymerase Chain Reaction market in the U.S. is estimated at US$2.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Polymerase Chain Reaction Market - Key Trends and Drivers Summarized

Polymerase Chain Reaction: A Cornerstone of Modern Molecular Biology

Polymerase Chain Reaction (PCR) is a revolutionary technique in molecular biology that allows for the amplification of specific DNA sequences. Developed by Kary Mullis in 1983, PCR enables researchers to produce millions of copies of a particular DNA segment in a relatively short amount of time. The process involves repeated cycles of heating and cooling, which facilitate the denaturation of the DNA double helix, the annealing of primers to target sequences, and the extension of these primers by a DNA polymerase enzyme. Typically, the reaction mixture contains the DNA template, two primers, free nucleotides, a buffer solution, and the thermostable DNA polymerase, such as Taq polymerase, which can withstand the high temperatures required for denaturation. This cyclical process results in the exponential amplification of the target DNA region, making PCR an indispensable tool in genetic research, diagnostics, and forensic science.

How Is PCR Utilized Across Different Fields?

PCR is utilized extensively across various scientific and medical fields due to its ability to rapidly and accurately amplify DNA. In medical diagnostics, PCR is employed to detect and quantify pathogens, such as bacteria and viruses, enabling the identification of infections like HIV, hepatitis, and COVID-19. Genetic testing also benefits from PCR, as it can identify mutations associated with hereditary diseases, facilitating early diagnosis and personalized treatment plans. In the field of forensic science, PCR is crucial for analyzing minute DNA samples from crime scenes, providing evidence that can link suspects to criminal activities. Additionally, PCR plays a significant role in research and development within biotechnology and pharmaceutical industries, where it is used for cloning, gene expression analysis, and the creation of genetically modified organisms. The versatility and precision of PCR make it an essential technique for advancing our understanding of genetics and improving public health and safety.

What Are the Current Trends in PCR Technology and Applications?

The technology and applications of PCR are continuously evolving, driven by advancements in molecular biology and the increasing demand for rapid and accurate genetic analysis. One significant trend is the development of quantitative PCR (qPCR), also known as real-time PCR, which allows for the quantification of DNA or RNA in real-time, providing valuable insights into gene expression and viral load. Digital PCR (dPCR) is another innovation, offering higher precision and sensitivity by partitioning the sample into thousands of individual reactions, enabling absolute quantification of nucleic acids. Advances in microfluidics are leading to the creation of portable PCR devices, making it possible to conduct genetic testing in resource-limited settings or in the field. Additionally, multiplex PCR, which can amplify multiple targets in a single reaction, is enhancing the efficiency of genetic testing by reducing time and reagent consumption. These trends reflect the ongoing efforts to improve the accuracy, efficiency, and accessibility of PCR, expanding its potential applications in diverse fields.

What Factors Are Driving the Growth in the PCR Market?

The growth in the PCR market is driven by several factors, reflecting the increasing demand for advanced genetic analysis and diagnostic tools. The expansion of the healthcare sector, particularly the rising prevalence of infectious diseases and the need for early diagnosis, is a significant driver for PCR technology. Technological advancements, such as the development of qPCR and dPCR, are enhancing the capabilities and accuracy of PCR, encouraging its adoption in various applications. The growing focus on personalized medicine and the need for precise genetic testing to guide treatment decisions are also propelling market growth. Additionally, the rise in research and development activities within biotechnology and pharmaceutical industries is boosting the demand for PCR in drug discovery and genetic engineering. The increasing use of PCR in forensic science and environmental monitoring further supports market expansion. Continuous research and development efforts to innovate and improve PCR technologies ensure robust growth in the PCR market, underscoring its essential role in advancing molecular biology and improving public health outcomes.

SCOPE OF STUDY:

The report analyzes the Polymerase Chain Reaction market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector, Other End-Uses); Segment (Instruments, Reagents & Consumables)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 17 Featured) -

  • Abbott Molecular, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • QIAGEN NV
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Polymerase Chain Reaction - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Molecular Diagnostics Propels Market Growth
    • Advances in PCR Technologies and Techniques Drives Adoption
    • Increasing Use in Infectious Disease Detection Expands Market Opportunities
    • Growth in Genetic and Genomic Research Strengthens Business Case for PCR
    • Development of Real-Time and Digital PCR Spurs Market Expansion
    • Expansion of Oncology and Cancer Research Generates Demand
    • Increasing Focus on Personalized Medicine Accelerates Market Growth
    • Enhanced Sensitivity and Specificity of Modern PCR Sustains Market Demand
    • Rising Investments in Biotechnology Research and Development Expands Addressable Market
    • Technological Innovations in PCR Reagents and Consumables Strengthens Market Position
    • Growth in Forensic and Clinical Applications Propels Market Growth
    • Increasing Demand for PCR in Agricultural and Food Testing Sustains Market Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Clinical Diagnostic Labs & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Clinical Diagnostic Labs & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Clinical Diagnostic Labs & Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Pharmaceutical & Biotechnology Sector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Pharmaceutical & Biotechnology Sector by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Polymerase Chain Reaction Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Polymerase Chain Reaction by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Polymerase Chain Reaction by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Polymerase Chain Reaction by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Polymerase Chain Reaction by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Polymerase Chain Reaction Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Polymerase Chain Reaction by Segment - Instruments and Reagents & Consumables Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Polymerase Chain Reaction by Segment - Percentage Breakdown of Value Sales for Instruments and Reagents & Consumables for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Polymerase Chain Reaction by End-Use - Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Polymerase Chain Reaction by End-Use - Percentage Breakdown of Value Sales for Academic & Research Institutes, Clinical Diagnostic Labs & Hospitals, Pharmaceutical & Biotechnology Sector and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION